Literature DB >> 31395383

Investigation of epigenetics in kidney cell biology.

Linda Xiaoyan Li1, Ewud Agborbesong1, Lu Zhang1, Xiaogang Li2.   

Abstract

Epigenetics is the study of heritable changes in DNA or its associated proteins except mutations in gene sequence. Epigenetic regulation plays fundamental roles in the processes of kidney cell biology through the action of DNA methylation, chromatin modifications via epigenetic regulators and interaction via transcription factors, and noncoding RNA species. Kidney diseases, including acute kidney injury, chronic kidney disease, nephritic and nephrotic syndromes, pyelonephritis and polycystic kidney diseases are driven by aberrant activity in numerous signaling pathways in even individual kidney cell. Epigenetic alterations, including DNA methylation, histone acetylation and methylation, noncoding RNAs, and protein posttranslational modifications, could disrupt essential pathways that protect the renal cells from uncontrolled growth, apoptosis and establishment of other renal associated syndromes, which have been recognized as one of the critical mechanisms for regulating functional changes that drive and maintain the kidney disease phenotype. In this chapter, we briefly summarize the epigenetic mechanisms in kidney cell biology and epigenetic basis of kidney development, and introduce epigenetic techniques that can be used in investigating the molecular mechanism of kidney cell biology and kidneys diseases, primarily focusing on the integration of DNA methylation and chromatin immunoprecipitation technologies into kidney disease associated studies. Future studies using these emerging technologies will elucidate how alterations in the renal cell epigenome cooperate with genetic aberrations for kidney disease initiation and progression. Incorporating epigenomic testing into the clinical research is essential to future studies with epigenetics biomarkers and precision medicine using emerging epigenetic therapies.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisulfite conversion; Chromatin; DNA methylation; Epigenetics; Histone modification; Kidney

Mesh:

Substances:

Year:  2019        PMID: 31395383     DOI: 10.1016/bs.mcb.2019.04.015

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  5 in total

Review 1.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 2.  Perspectives in systems nephrology.

Authors:  Maja T Lindenmeyer; Fadhl Alakwaa; Michael Rose; Matthias Kretzler
Journal:  Cell Tissue Res       Date:  2021-05-24       Impact factor: 4.051

3.  Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice.

Authors:  Binbin Cui; Xiying Hou; Mengjun Liu; Qing Li; Chao Yu; Shenglei Zhang; Yi Wang; Jun Wang; Shougang Zhuang; Feng Liu
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

4.  Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1-Drp1 signalling pathway.

Authors:  Zhaowei Chen; Wei Liang; Jijia Hu; Zijing Zhu; Jun Feng; Yiqiong Ma; Qian Yang; Guohua Ding
Journal:  Cell Prolif       Date:  2022-07-17       Impact factor: 8.755

Review 5.  Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases.

Authors:  J P Jose Merlin; Xiaogang Li
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.